Disease-associated protein

Details for Australian Patent Application No. 2002312794 (hide)

Owner Universite Louis Pasteur Novartis AG

Inventors Hicks, David; Mohand-Said, Saddek; Leveillard, Thierry

Agent Davies Collison Cave

Pub. Number AU-B-2002312794

PCT Number PCT/EP02/03810

PCT Pub. Number WO2002/081513

Priority 01/04712 06.04.01 FR

Filing date 5 April 2002

Wipo publication date 21 October 2002

Acceptance publication date 1 December 2005

International Classifications

C07K 014/47 Peptides having more than 20 amino acids

Event Publications

2 January 2003 Complete Application Filed

  Priority application(s): 01/04712 06.04.01 FR

10 April 2003 Application Open to Public Inspection

  Published as AU-B-2002312794

1 December 2005 Application Accepted

  Published as AU-B-2002312794

12 January 2006 Corrigenda

  Applications Accepted - Name Index Under the names Universite Louis Pasteur and Novartis AG, Application No. 2002312794, under INID (72) insert the co-inventor Sahel, Jose Alain.

30 March 2006 Standard Patent Sealed

24 December 2009 Amendment Made

  The nature of the amendment is: Amend the co-patentee name from Universite Louis Pasteur to Universite de Strasbourg

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002312795-METHOD FOR THE PRODUCTION OF Delta1 PYRROLINES

2002312793-DEVICE FOR CONTROLLING A CLOSED CIRCUIT CURRENT FOR AN AMPLIFIER TRANSISTOR AND AMPLIFIER CIRCUIT